70771-1601-7 : NDC 2026 Code

70771-1601-7 : Verapamil Hydrochloride ( Verapamil Hydrochloride )

Additionally :

You can get information about “70771-1601-7” NDC code in 70771-1601-7 in HTML format

HTML | 70771-1601-7 in TXT (Plain Text) format

TXT | 70771-1601-7 in PDF (Portable Document Format)

PDF | 70771-1601-7 in XML format

XML formats.

NDC Code : 70771-1601-7 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "70771-1601-7",
    "PackageDescription": "25 CARTON in 1 CARTON (70771-1601-7)  &gt; 5 VIAL in 1 CARTON (70771-1601-5)  &gt; 2 mL in 1 VIAL (70771-1601-1) ",
    "NDC11Code": "70771-1601-07",
    "ProductNDC": "70771-1601",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Verapamil Hydrochloride",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Verapamil Hydrochloride",
    "DosageFormName": "INJECTION, SOLUTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20201022",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA214215",
    "LabelerName": "Zydus Lifesciences Limited",
    "SubstanceName": "VERAPAMIL HYDROCHLORIDE",
    "StrengthNumber": "2.5",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2022-11-09",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20201022",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}